Mai‐Yee Luk

729 total citations
28 papers, 465 citations indexed

About

Mai‐Yee Luk is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Mai‐Yee Luk has authored 28 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Otorhinolaryngology and 10 papers in Surgery. Recurrent topics in Mai‐Yee Luk's work include Head and Neck Cancer Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Mai‐Yee Luk is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Mai‐Yee Luk collaborates with scholars based in China, Hong Kong and Canada. Mai‐Yee Luk's co-authors include Irene Cheung, Paul S. F. Yip, Rth Ho, Victor Lee, Chi‐Chung Tong, Ted C. T. Fong, To‐Wai Leung, Cheuk‐Wai Choi, Sum‐Yin Chan and Dora Lai‐Wan Kwong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Mai‐Yee Luk

28 papers receiving 462 citations

Peers

Mai‐Yee Luk
Bhupesh Parashar United States
C Glover United Kingdom
Emily Nash Smyth United States
O. Donnay Spain
Yuk Tung China
Ágnes Ruzsa Hungary
Kelly M. de Ligt Netherlands
Bhupesh Parashar United States
Mai‐Yee Luk
Citations per year, relative to Mai‐Yee Luk Mai‐Yee Luk (= 1×) peers Bhupesh Parashar

Countries citing papers authored by Mai‐Yee Luk

Since Specialization
Citations

This map shows the geographic impact of Mai‐Yee Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai‐Yee Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai‐Yee Luk more than expected).

Fields of papers citing papers by Mai‐Yee Luk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai‐Yee Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai‐Yee Luk. The network helps show where Mai‐Yee Luk may publish in the future.

Co-authorship network of co-authors of Mai‐Yee Luk

This figure shows the co-authorship network connecting the top 25 collaborators of Mai‐Yee Luk. A scholar is included among the top collaborators of Mai‐Yee Luk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai‐Yee Luk. Mai‐Yee Luk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Sullivan, Brian, Shao Hui Huang, Ka-On Lam, et al.. (2022). An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma. Cancers. 14(8). 1923–1923. 3 indexed citations
2.
Lam, Ka-On, Sum‐Yin Chan, Ivan Hung, et al.. (2021). Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report. BMC Infectious Diseases. 21(1). 1148–1148. 7 indexed citations
4.
Choi, Cheuk‐Wai, Ka-On Lam, Sum‐Yin Chan, et al.. (2021). The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis. Frontiers in Oncology. 11. 626145–626145. 11 indexed citations
6.
Wong, Tiffany, Victor Lee, Herbert Pang, et al.. (2021). Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant. Hepatology. 74(5). 2580–2594. 38 indexed citations
7.
Tsoi, Ho, Lai‐San Wong, Wing‐Lok Chan, et al.. (2021). Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer. SHILAP Revista de lepidopterología. 11(11). e578–e578. 10 indexed citations
8.
9.
Chan, Wing‐Lok, Kwok‐Leung Cheung, Cheuk‐Wai Choi, et al.. (2020). The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer. Journal of Geriatric Oncology. 12(4). 557–562. 18 indexed citations
10.
Nicholls, John M., Victor Lee, Cheuk‐Wai Choi, et al.. (2019). Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes. British Journal of Cancer. 121(8). 690–698. 25 indexed citations
11.
Wong, Tiffany, Chi‐Leung Chiang, Ann‐Shing Lee, et al.. (2019). Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis. Surgical Oncology. 28. 228–235. 24 indexed citations
12.
Gong, Chun, Ellen P.S. Man, Ho Tsoi, et al.. (2018). BQ323636.1, a Novel Splice Variant to NCOR 2, as a Predictor for Tamoxifen-Resistant Breast Cancer. Clinical Cancer Research. 24(15). 3681–3691. 19 indexed citations
13.
Lee, Victor, Dora Lai‐Wan Kwong, To‐Wai Leung, et al.. (2018). The addition of pretreatment plasma Epstein–Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification. International Journal of Cancer. 144(7). 1713–1722. 80 indexed citations
14.
Kwok, Philip Chong‐hei, Stephen L. Chan, Ann‐Shing Lee, et al.. (2018). Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma. Liver Cancer. 7(1). 40–54. 26 indexed citations
15.
Tong, Chi‐Chung, Ching Wan Lam, Ka On Lam, Victor Lee, & Mai‐Yee Luk. (2018). A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening. Frontiers in Oncology. 8. 279–279. 12 indexed citations
16.
Lee, Victor, Dora L.�W. Kwong, Cheuk‐Wai Choi, et al.. (2018). 5-Year Results of the Prognostic Roles of Serial Post-Intensity-Modulated Radiation Therapy Undetectable Plasma EBV DNA for Non-Metastatic Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 102(3). S126–S127. 1 indexed citations
17.
Ho, Rth, Ted C. T. Fong, Irene Cheung, Paul S. F. Yip, & Mai‐Yee Luk. (2016). Effects of a Short-Term Dance Movement Therapy Program on Symptoms and Stress in Patients With Breast Cancer Undergoing Radiotherapy: A Randomized, Controlled, Single-Blind Trial. Journal of Pain and Symptom Management. 51(5). 824–831. 89 indexed citations
18.
Lee, Victor, Denis H. Y. Leung, Mai‐Yee Luk, et al.. (2015). Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma. OncoTargets and Therapy. 8. 3457–3457. 10 indexed citations
19.
20.
Tong, Chi‐Chung, et al.. (2002). Cervical nodal metastases from occult primary: Undifferentiated carcinoma versus squamous cell carcinoma. Head & Neck. 24(4). 361–369. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026